Bolt Biotherapeutics Inc (BOLT)
0.7460
0.00 (0.00%)
USD |
NASDAQ |
Jun 28, 16:00
0.744
0.00 (0.00%)
Pre-Market: 20:00
Bolt Biotherapeutics Total Assets (Quarterly): 142.89M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 142.89M |
| December 31, 2023 | 159.78M |
| September 30, 2023 | 175.36M |
| June 30, 2023 | 190.70M |
| March 31, 2023 | 206.18M |
| December 31, 2022 | 227.81M |
| September 30, 2022 | 245.50M |
| June 30, 2022 | 260.24M |
| Date | Value |
|---|---|
| March 31, 2022 | 282.79M |
| December 31, 2021 | 307.72M |
| September 30, 2021 | 333.55M |
| June 30, 2021 | 347.07M |
| March 31, 2021 | 324.64M |
| December 31, 2020 | 46.54M |
| September 30, 2020 | 61.74M |
| December 31, 2019 | 48.45M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
46.54M
Minimum
Dec 2020
347.07M
Maximum
Jun 2021
210.06M
Average
216.99M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 3.534M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 38.73M |
| Shareholders Equity (Quarterly) | 104.16M |
| Current Ratio | 5.684 |